Ken Stern & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $665K | Buy |
7,027
+1
| +0% | +$95 | 0.29% | 47 |
|
|
2018
Q2 | $651K | Buy |
7,026
+57
| +0.8% | +$5.28K | 0.3% | 38 |
|
|
2018
Q1 | $660K | Sell |
6,969
-44
| -0.6% | -$4.17K | 0.29% | 34 |
|
|
2017
Q4 | $678K | Sell |
7,013
-57
| -0.8% | -$5.51K | 0.3% | 37 |
|
|
2017
Q3 | $630K | Sell |
7,070
-133
| -2% | -$11.9K | 0.28% | 39 |
|
|
2017
Q2 | $520K | Buy |
7,203
+1
| +0% | +$72 | 0.24% | 48 |
|
|
2017
Q1 | $475K | Sell |
7,202
-59
| -0.8% | -$3.89K | 0.22% | 54 |
|
|
2016
Q4 | $455K | Sell |
7,261
-56
| -0.8% | -$3.51K | 0.24% | 57 |
|
|
2016
Q3 | $462K | Buy |
7,317
+1
| +0% | +$63 | 0.32% | 46 |
|
|
2016
Q2 | $453K | Buy |
7,316
+99
| +1% | +$6.13K | 0.36% | 43 |
|
|
2016
Q1 | $412K | Buy |
7,217
+1,350
| +23% | +$77.1K | 0.29% | 46 |
|
|
2015
Q4 | $348K | Buy |
5,867
+17
| +0.3% | +$1.01K | 0.23% | 61 |
|
|
2015
Q3 | $318K | Buy |
5,850
+802
| +16% | +$43.6K | 0.25% | 53 |
|
|
2015
Q2 | $339K | Buy |
5,048
+523
| +12% | +$35.1K | 0.25% | 42 |
|
|
2015
Q1 | $465K | Buy |
+4,525
| New | +$465K | 0.35% | 40 |
|